Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter and Conference Paper
Glivec (imatinib) bremst das Pankreaskarzinomwachstum in vitro — ein neuer Therapieansatz in der Behandlung des Pankreaskarzinoms?
Autocrine and paracrine growth regulating loops contribute to the aggressiveness of pancreatic carcinoma, one of the most lethal human cancers, in which incidence and mortality almost coincide. The evaluation ...
-
Chapter and Conference Paper
Der Arylhydrocarbon Rezeptor als neue Zielscheibe zur Behandlung des Pankreaskarzinoms
The arylhydrocarbon receptor (AhR) was initially identified as a member of the adaptive metabolic and toxic response pathway to polycyclic aromatic hydrocarbons and to halogenated dibenzo-p-dioxins and dibenzo...